Pharma Stocks India

This CDMO Firm Is Building in the Right Places

by

Custom synthesis growing 17%, peptides scaling, contrast media under long-term contracts Among India’s pharmaceutical API manufacturers, Divi’s Laboratories occupies a rare position — a company trusted by global innovators with complex, long-duration supply relationships that are difficult to replicate and even more difficult to dislodge. The fourth quarter of FY26 delivered a steady set of … Read more

This Company Is Quietly Building One of India’s Most Interesting CDMO Businesses

by

Record margins, a Bio segment scaling fast, CDMO contribution set to double by FY30  There is a version of the Laurus Labs story that is genuinely exciting — a pharma company that began as an ARV API supplier and has, over the last several years, methodically built a contract development and manufacturing business serving global … Read more